• 1
    American Cancer Society. Cancer Facts and Figures 2008. Atlanta, GA: American Cancer Society; 2008.
  • 2
    American Cancer Society. Cancer Facts and Figures for African Americans 2007-2008. Atlanta, GA: American Cancer Society; 2007.
  • 3
    Carether JM. Racial and ethnic factors in the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor Phys. 1999; 10: 59-67.
  • 4
    Wu XC, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States. 1992-1997. Cancer. 2001; 92: 2547-2554.
  • 5
    Ashktorab H, Smoot DT, Carethers JM, et al. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003; 9: 1112-1117.
  • 6
    Mostafa G, Matthews BD, Norton HJ, Kercher KW, Sing RF, Heniford BT. Influence of demographics on colorectal cancer. Am Surg. 2004; 70: 259-264.
  • 7
    Ashktorab H, Smoot DT, Farzanmehr H, et al. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer. 2005; 116: 914-919.
  • 8
    Ries LAG, Harkin D, Krapcho M, et al, eds. Surveillance Epidemiology and End Results cancer statistics review, 1975-2003, National Cancer Institute. Available at: Accessed March 17, 2007.
  • 9
    Ko CW, Krueter W, Baldwin LM. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol. 2005; 5: 10.
  • 10
    Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004; 100: 2093-2103.
  • 11
    Vlahov D, Ahern J, Vazquez T, et al. Racial/ethnic differences in screening for colon cancer: report from the New York cancer project. Ethn Dis. 2005; 15: 76-83.
  • 12
    McMahon LF, Wolfe RA, Huang S, Tedeschi P, Manning W, Edlund MJ. Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care. 1999; 37: 712-717.
  • 13
    Rao RS, Graubard BI, Breen N, Gastwirth JL. Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care. 2004; 42: 789-800.
  • 14
    Felix-Aaron K, Moy E, Kang M, Patel M, Chesley FD, Clancy C. Variation in quality of men's healthcare by race/ethnicity and social class. Med Care. 2005; 43: 172-181.
  • 15
    Tabbarah M, Nowalk MP, Raymund M, Jewell IK, Zimmerman RK. Barriers and facilitators of colon cancer screening among patients at faith based neighborhood health centers. J Community Health. 2005; 30: 55-74.
  • 16
    Lafata JE, Cole Johnson C, Ben-Menachem T, Morlock RJ. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. Med Care. 2001; 39: 361-372.
  • 17
    Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002; 20: 3999-4005.
  • 18
    Rogers SO, Ray WA, Smalley WE. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? Cancer Causes Control. 2004; 15: 193-199.
  • 19
    Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005; 97: 1211-1220.
  • 20
    Ball JD, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996; 34: 970-984.
  • 21
    Mayberry RM, Mili F, Ofili E. Racial and ethnic differences in access to medical care. Med Care Res Rev. 2000; 57( suppl 1): 163-197.
  • 22
    Demissie K, Oluwole OO, Balasubramanian BA, Osinubi OO, August D, Rhoads GG. Racial differences in treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks. Ann Epidemiol. 2004; 14: 215-221.
  • 23
    Govindarajan R, Shah RV, Erkman LG, Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003; 97: 493-498.
  • 24
    Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003; 21: 1293-1300.
  • 25
    Cronin DP, Harlan LC, Potosky AL, Clegg LX, Stevens JL, Mooney MM. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol. 2006; 101: 2308-2318.
    Direct Link:
  • 26
    Wudel LJ Jr, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002; 137: 550-556.
  • 27
    McCollum AD, Catalano PJ, Haller DG, et al. Outcomes and toxicity in African-American and Caucasians patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002; 94: 1160-1167.
  • 28
    Graiser M, Moore SG, Victor R, et al. Development of query strategies to identify a histologic lymphoma subtype in a large linked database system. Cancer Inform. 2007; 3: 149-158.
  • 29
    National Academy of Sciences. Envisioning the National Health Care Quality Report. Available at: 030907343X/html Accessed May 16, 2005.
  • 30
    The NCCN Clinical Practice Guidelines in Oncology Colon Cancer (Version 1.2006). National Comprehensive Cancer Network, Inc. 2006. Available at: Accessed on October 26, 2006.
  • 31
    American Society of Clinical Oncology. Quality Oncology Practice Initiative. Available at: Accessed on May 16, 2005.
  • 32
    Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington, DC: Institute of Medicine of the National Academies Press; 2003.
  • 33
    Healthy People 2010. Cancer. Available at: Accessed August 1, 2005.
  • 34
    Healthy People 2010. A Systematic Approach to Health Improvement 2000. Available at: Accessed August 1, 2005.
  • 35
    Trans-Health and Human Services Cancer Health Disparities Progress Review Group. Making Cancer Health Disparities History. Washington, DC: US Department of Health and Human Services; 2004.
  • 36
    President's Cancer Panel Report of the Chairman 2000-2001. Voices of a Broken System: Real People, Real Problems (DHHS NIH Publication No. 03-5301). Washington, DC: US Government Printing Office; 2002.
  • 37
    Cooper GS, Koroukian SM. Racial disparities in the use of and indication for colorectal procedures in Medicare beneficiaries. Cancer. 2004; 100: 418-424.
  • 38
    Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005; 104: 629-639.
  • 39
    O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005; 165: 2129-2135.
  • 40
    Akerley WL III, Moritz TE, Ryan LS, et al. Racial comparison of outcomes of male department of Veterans Affairs patients with lung and colon cancer. Arch Intern Med. 1993; 153: 1681-1688.
  • 41
    Dominitz JA. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998; 82: 2312-2320.
  • 42
    Dignam JJ, Colangelo L, Tian W, et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the national surgical adjuvant breast and bowel project. J Natl Cancer Inst. 1999; 91: 1933-1940.
  • 43
    Dolan NC, Ferreira MR, Fitzgibbon ML, et al. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. 2005; 28: 479-482.
  • 44
    Bradley CJ, Charles GW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001; 91: 178-188.
  • 45
    Schwartz KL, Crossley-May H, Vigneau FD, Brown K, Banerjee M. Race, socioeconomic status, and stage at diagnosis for 5 common malignancies. Cancer Causes Control. 2003; 14: 716-766.
  • 46
    Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007; 109: 612-620.
  • 47
    Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996; 86: 1794-1797.
  • 48
    Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc. 2007; 99: 723-728.
  • 49
    U.S. Census Bureau. Income, Poverty, and Health Insurance Coverage in the United States: 2007 (U.S. Census Bureau Current Population Reports No. P60-235). Washington, DC: US Government Printing Office; 2008.
  • 50
    Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9: 222-231.
  • 51
    Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008; 58: 9-31.
  • 52
    Donabedian A. The quality of care: how can it be assessed? JAMA. 1988; 260: 1743-1748.
  • 53
    Kelley E, Moy E, Stryer D, et al. The national healthcare quality and disparities reports: an overview. Med Care 2005; 43( suppl 3): 3-8.